ストックスクリーナーアプリを入手
0.9276
4.37%
-0.0424
アフターアワーズ：
.92
-0.0076
-0.82%
前日終値:
$0.97
開ける：
$0.9799
24時間の取引高:
117.16K
Relative Volume:
0.23
時価総額：
$13.98M
収益：
$356.60K
当期純損益:
$-24.32M
株価収益率:
-0.1004
EPS:
-9.24
ネットキャッシュフロー:
$-27.24M
1週間 パフォーマンス:
-8.16%
1か月 パフォーマンス:
-10.81%
6か月 パフォーマンス:
-52.43%
1年 パフォーマンス:
-41.66%
1日の値動き範囲:
$0.9201
$0.9799
1週間の範囲:
$0.8981
$1.03
52週間の値動き範囲:
$0.73
$11.18
Geovax Labs Inc Stock (GOVX) Company Profile
GOVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.9276 | 13.98M | 356.60K | -24.32M | -27.24M | -9.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-15 | 繰り返されました | Alliance Global Partners | Buy |
| 2025-04-15 | 繰り返されました | D. Boral Capital | Buy |
| 2024-11-11 | 開始されました | Alliance Global Partners | Buy |
| 2024-07-16 | 開始されました | ROTH MKM | Buy |
| 2020-11-19 | 開始されました | Maxim Group | Buy |
Geovax Labs Inc (GOVX) 最新ニュース
GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025 - Yahoo Finance
GeoVax Strengthens Patent Portfolio for Innovative Cancer Therapy Approach - citybuzz -
GeoVax Expands Gedeptin(R) Patent Portfolio - Yahoo Finance
GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production - Yahoo Finance
Geovax highlights progress on mpox vaccine and COVID-19 trial advancements - MSN
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia - ADVFN
D. Boral Capital Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $9.00 - Defense World
GeoVax Labs, Inc. (NASDAQ:GOVX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Form 8-KCurrent report - ADVFN
Geode Capital Management LLC Has $223,000 Holdings in GeoVax Labs, Inc. (NASDAQ:GOVX) - Defense World
GeoVax Labs Earnings Call: Mixed Sentiment and Future Prospects - TipRanks
Geovax Labs (GOVX) Faces Price Target Reduction by Analyst | GOV - GuruFocus
Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
GeoVax Labs Reports Q1 2025 Progress Amid Challenges - TipRanks
Earnings call transcript: GeoVax Q1 2025 reveals revenue from BARDA contract - Investing.com
GeoVax Labs Q1 2025 Earnings Call Transcript - MarketBeat
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting - Yahoo Finance
Geovax Labs is a buy, Roth says - Cantech Letter
GOVX’s 2023 Market Dance: Down -59.51% – Time to Invest? - investchronicle.com
Geovax Labs Inc (GOVX) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater - Yahoo Finance
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress - Yahoo Finance
GeoVax to Host Q1 2025 Financial Results Conference Call, Spotlight COVID-19 Vaccine and Cancer Therapy Progress - citybuzz -
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025 - The Globe and Mail
GeoVax Bolsters Technical Development with Seasoned Biologics Executive - citybuzz -
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations - The Globe and Mail
Analysts Issue Forecasts for GeoVax Labs FY2029 Earnings - Defense World
HC Wainwright Estimates GeoVax Labs FY2025 Earnings - Defense World
Alliance Global Partners Cuts GeoVax Labs (NASDAQ:GOVX) Price Target to $8.50 - Defense World
HC Wainwright Reiterates Buy Rating for GeoVax Labs (NASDAQ:GOVX) - Defense World
Q2 EPS Estimates for GeoVax Labs Lowered by Noble Financial - Defense World
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates - Yahoo Finance
GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital - Yahoo Finance
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum - Yahoo Finance
Geovax Labs stock hits 52-week low at $0.78 amid market challenges By Investing.com - Investing.com South Africa
Top Midday Decliners - marketscreener.com
These Numbers Reveal How Powerful Geovax Labs Inc (NASDAQ: GOVX) Stock Is - stocksregister.com
GeoVax Labs (GOVX) Faces Setback with Price Target Reduced by Ro - GuruFocus
GeoVax Labs (GOVX) Faces Setback with Price Target Reduced by Roth Capital | GOVX Stock News - GuruFocus
GeoVax to Present at the Emerging Growth Conference on April 16, 2025 - Yahoo Finance
GeoVax (GOVX) Faces Setback with Termination of COVID-19 Vaccine Project | GOVX Stock News - GuruFocus
GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall - marketscreener.com
GeoVax Labs (GOVX) Faces Setback as BARDA-Funded Trial Ends | GO - GuruFocus
Geovax Labs stock hits 52-week low at $0.78 amid market challenges - Investing.com Canada
GeoVax to Present Clinical Data at Upcoming April Industry Events - Yahoo Finance
GeoVax Labs (GOVX): Price Target Lowered Amid BARDA Project Pause | GOVX Stock News - GuruFocus
GeoVax Labs contract with BARDA terminated By Investing.com - Investing.com South Africa
GeoVax Labs Got Written Notification From Advanced Technology International - MarketScreener
GeoVax tumbles as HHS ends mid-stage COVID vaccine trial - TradingView
GeoVax Labs contract with BARDA terminated - Investing.com
Geovax Labs Inc (GOVX) 財務データ
収益
当期純利益
現金流量
EPS
Geovax Labs Inc (GOVX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
| DODD DAVID A | President, CEO |
Aug 09 '24 |
Buy |
1.95 |
8,000 |
15,600 |
26,661 |
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):